Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More
Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More
Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More
CEO Matt Coffey will participate in the Off-the-Shelf CAR T - solid tumors, myeloma, lymphoma panel at Canaccord’s… https://t.co/DlQMsCYZRD
RT @LifeSciAdvisors: Join us for the @Oncolytics KOL Webinar on AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer…